Cite
MLA Citation
E. Alexeeva et al.. “THU0506 LONG-TERM EFFECTIVENESS AND SAFETY OF CANAKINUMAB AS A SECOND BIOLOGIC AFTER TOCILIZUMAB IN CHILDREN WITH EARLY AND LATE JIA WITH ACTIVE SYSTEMIC FEATURES.” Annals of the rheumatic diseases, vol. 79, n.d., pp. 491–492. http://access.bl.uk/ark:/81055/vdc_100144725655.0x000048